The Welsh pharmacy sector is set to receive a significant boost with an additional £7 million investment as part of the latest Community Pharmacy Contractual Framework (CPCF) agreement for the years 2025-26. This announcement, made on November 20, 2023, marks a pivotal moment for community pharmacies in Wales, highlighting the government’s commitment to enhancing healthcare access and support through local pharmacy resources.
As outlined in the agreement between the Welsh government, the NHS, and Community Pharmacy Wales (CPW), this year will see a 4% increase in funding. This rise is not just a fleeting enhancement; it elevates the total funding for the CPCF in Wales to an impressive £182 million, representing nearly a 30% increase since the 2016-17 fiscal year. Such funding growth underscores a growing recognition of the essential services community pharmacies provide.
Jeremy Miles, the Welsh government’s cabinet secretary for health and social care, indicated that the funding increase aligns with the NHS Pay Review Body recommendations for Doctors and Dentists (DDRB), which will now extend to community pharmacy. In his statement, Miles emphasized that this record level of investment acknowledges the critical role that community pharmacies play, as well as the dedication of their teams. “The measures agreed as part of this funding package will help ensure the NHS maximizes the use of the skills and expertise of pharmacists, pharmacy technicians and the wider pharmacy team in every community in Wales,” he remarked.
This funding increase not only addresses immediate financial pressures but also aims to support the sector in overcoming ongoing challenges. With community pharmacies continuing to transform and adapt their services, this investment is positioned to reinforce the Welsh government’s broader ambitions for healthcare reform.
In September, the Royal Pharmaceutical Society (RPS) laid out three-year goals to advance pharmacy services across Wales, initiatives that resonate with this recent funding injection. A focal point of these goals includes enhancing patient access to independent prescribers and creating innovative career pathways to attract and retain talent within the pharmacy profession.
Despite the positive news surrounding the increased funding, there are ongoing concerns within the community pharmacy community. A spokesperson for CPW noted that, while the board welcomes the additional funds, they have been vocal throughout negotiations about the insufficiency of current funding levels. “Without further support, contractors will be forced to make difficult business decisions that could adversely affect the delivery of community pharmacy clinical services and limit the sector’s ability to embrace future reforms,” the spokesperson expressed, highlighting the precarious financial landscape that many pharmacies face.
Adding to these concerns, Malcolm Harrison, the chief executive of the Company Chemists’ Association, acknowledged the strain felt across the community pharmacy network. While he welcomed the 4% increase as a positive step forward in alleviating some immediate pressures, he emphasized the need for sustained investment. “The demand and workload in community pharmacies continues to grow at a pace that far exceeds current funding levels,” he stated, underlining the necessity of ongoing financial support to meet the evolving needs of the public and ensure that the Welsh government’s goals for healthcare are attainable.
As community pharmacies brace for the future, the latest funding agreement represents both an opportunity and a challenge. The commitment to enhance the sector is palpable, yet the reality of increasing demand and financial pressures looms large. The ongoing discussions and negotiations surrounding pharmacy funding will undoubtedly shape the landscape of healthcare in Wales in the coming years.
